LB de Arruda,
PR Chikhlikar,
JT August,
ET Marques.
(2004)
" DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response.
"
Immunology
112.
126-33
PMID:
15129672
|
Abstract and Keywords
LS Wyatt,
PL Earl,
JY Liu,
JM Smith,
DC Montefiori,
HL Robinson,
B Moss.
(2004)
" Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component.
"
AIDS Res Hum Retroviruses
20.
645-53
PMID:
15242542
DOI:
10.1089/0889222041217428
|
Abstract and Keywords
SA Sharpe,
A Cope,
S Dowall,
N Berry,
C Ham,
JL Heeney,
D Hopkins,
L Easterbrook,
M Dennis,
N Almond,
M Cranage.
(2004)
" Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope.
"
J Gen Virol
85.
2591-602
PMID:
15302953
DOI:
10.1099/vir.0.80050-0
|
Abstract and Keywords
U Wille-Reece,
CY Wu,
BJ Flynn,
RM Kedl,
RA Seder.
(2005)
" Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses.
"
J Immunol
174.
7676-83
PMID:
15944268
|
Abstract and Keywords
JP McGettigan,
ML Koser,
PM McKenna,
ME Smith,
JM Marvin,
LC Eisenlohr,
B Dietzschold,
MJ Schnell.
(2006)
" Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2.
"
Virology
344.
363-77
PMID:
16226782
DOI:
10.1016/j.virol.2005.09.004
|
Abstract and Keywords
GW Stone,
S Barzee,
V Snarsky,
K Kee,
CA Spina,
XF Yu,
RS Kornbluth.
(2006)
" Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.
"
J Virol
80.
1762-72
PMID:
16439533
DOI:
10.1128/JVI.80.4.1762-1772.2006
|
Abstract and Keywords
J Liu,
LS Wyatt,
RR Amara,
B Moss,
HL Robinson.
(2006)
" Studies on in vitro expression and in vivo immunogenicity of a recombinant MVA HIV vaccine.
"
Vaccine
24.
3332-9
PMID:
16472543
DOI:
10.1016/j.vaccine.2006.01.017
|
Abstract and Keywords
LM Chen,
G Briones,
RO Donis,
JE Galán.
(2006)
" Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development.
"
Infect Immun
74.
5826-33
PMID:
16988261
DOI:
10.1128/IAI.00375-06
|
Abstract and Keywords
K Santos,
CM Duke,
SM Rodriguez-Colon,
A Dakwar,
S Fan,
MC Keefer,
HJ Federoff,
JG Frelinger,
WJ Bowers,
S Dewhurst.
(2007)
" Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag.
"
Vaccine
25.
1634-46
PMID:
17145123
DOI:
10.1016/j.vaccine.2006.11.004
|
Abstract and Keywords
PL Earl,
JL Americo,
LS Wyatt,
LA Eller,
DC Montefiori,
R Byrum,
M Piatak,
JD Lifson,
RR Amara,
HL Robinson,
JW Huggins,
B Moss.
(2007)
" Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate.
"
Virology
366.
84-97
PMID:
17499326
DOI:
10.1016/j.virol.2007.02.041
|
Abstract and Keywords